Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Song, S. H
Right arrow Articles by Gray, T. A
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of type 2 diabetes and lipids: a critique of the NICE guidelines 2008

Soon H Song

Diabetes Centre, Northern General Hospital, Sheffield, UK, soon_song{at}hotmail.com

Trevor A Gray

Department of Clinical Chemistry, Northern General Hospital, Sheffield, UK

Type 2 diabetes and cardiovascular disease are leading causes of morbidity and mortality in the UK. Appropriate and effective management of these conditions and associated risk factors such as hyperlipidaemia are the cornerstones to improving general well being and health outcomes. In 2008, the National Institute for Health and Clinical Excellence (NICE) published guidelines on the management of type 2 diabetes (CG66) and lipid modification (CG67). This article aims to give a practical critique of the clinical management strategies recommended by these guidelines. Br J Diabetes vasc Dis 2009;9:69—74

Key Words: NICE guideline • type 2 diabetes • lipid modification

References

  • National Institute for Health and Clinical Excellence. Type 2 diabetes. The management of type 2 diabetes. NICE clinical guideline. London: NICE, 2008
  • National Institute for Health and Clinical Excellence. Lipid modification. Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guideline. London: NICE, 2008.
  • Davies M. Focus on glycaemic management: a veritable feast or a dog's dinner? Br J Diabetes Vasc Dis 2008;8:191-94.[Abstract/Free Full Text]
  • National Institute for Health and Clinical Excellence. Diabetes in pregnancy: management of diabetes and its complications from pre-conception to the postnatal period. NICE clinical guideline. London: NICE, 2008.
  • National Institute for Health and Clinical Excellence. Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children (CG43). NICE clinical guideline. London: NICE, 2006.
  • National Institute for Health and Clinical Excellence. Hypertension: management of hypertension in adults in primary care (partial update of CG18) CG34. NICE clinical guideline. London: NICE, 2006.
  • The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care 2007;30:1374-83.[Abstract/Free Full Text]
  • Davies MJ, Heller S., Skinner TC et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with type 2 diabetes: cluster randomized controlled trial. BMJ 2008;336:491-5.[Abstract/Free Full Text]
  • Lee S., Kuk JL, Davidson LE et al. Exercise without weight loss is an effective strategy for obesity reduction in obese individuals with and without type 2 diabetes. J Appl Physiol 2005;99:1220-5.[Abstract/Free Full Text]
  • Duncan GE, Perri MG, Theriaque DW et al. Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults. Diabetes Care 2003;26: 557-62.[Abstract/Free Full Text]
  • Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.[Abstract/Free Full Text]
  • The ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-9.[Abstract/Free Full Text]
  • The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-7.[Abstract/Free Full Text]
  • Nathan DM, Buse JB, Davidson MB et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009;52:17-30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Holman RR, Paul SJ, Bethel MA et al. Ten-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.[Abstract/Free Full Text]
  • Bailey CJ, Day C. Glycaemic memory. Br J Diabetes Vasc Dis 2008;8:242-7.[Abstract/Free Full Text]
  • Farmer A., Wade A., Goyder E. et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomized trial. BMJ 2007;335:132.[Abstract/Free Full Text]
  • Chia CW, Egan JW Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab 2008;93:3703-16.[Abstract/Free Full Text]
  • Erdmann E., Dormandy JA, Charbonel B. et al. PROactive Investigators. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction. J Am Coll Cardiol 2007;49:1772-80.[Abstract/Free Full Text]
  • Wilcox R., Bousser MG, Betteridge DJ et al. PROactive Investigators. Effect of pioglitazone in patients with type 2 diabetes with or without previous stroke. Results from PROactive (PROspective pioglitAzone Clinical Trial in macroVascular Events 04). Stroke 2007;38:865-73.[Abstract/Free Full Text]
  • Kahn SE, Haffner SM, Heise MA et al. Glycaemic durability of rosiglitazone, metformin or glyburide monotherapy. N Engl J Med 2006; 355:2427-43.[Abstract/Free Full Text]
  • Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356:2457-71.[Abstract/Free Full Text]
  • Singh S., Loke YK, Furberg CD Long term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007;298:1189-95.[Abstract/Free Full Text]
  • Lincoff AM, Wolski K., Nicholls SJ et al. Pioglitazone and the risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007;289:1180-8.
  • Selvin E., Bolen S., Yeh HC et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch Intern Med 2008;16:2070-80.
  • British Cardiac Society, British Hypertension Society, Heart UK, Primary Care Cardiovascular Society, Stroke Society. Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl V):v1-v52[Free Full Text]
  • Hillier TA, Pedula KL Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 2003;26:2999-305.[Abstract/Free Full Text]
  • Song SH Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk? Br J Diabetes Vasc Dis 2008;5:61-5.
  • Song SH, Hardisty CA Cardiovascular risk profile of early and later onset type 2 diabetes. Practical Diabetes Int 2007;24:20-4.[CrossRef]
  • Song SH, Hardisty CA Diagnosing metabolic syndrome in type 2 diabetes: does it matter? QJM 2008;101:487-91.[Abstract/Free Full Text]
  • Assmann G., Schulte H. Triglyceride and atherosclerosis: results from the Prospective Cardiovascular Munster Study. Arterioscler Rev 1991;22:51-7.
  • Austin MA, Hokanson JE, Edwards KL Hypertrigylceridaemia as a cardiovascular risk factor. Am J Cardiol 1998; 81(4A):7B-12B.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kesaniemi YA Serum triglycerides and clinical benefit in lipid lowering trials. Am J Cardiol 1998; 81(4A):70B-73B.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Keech A., Simes RJ, Barter P. et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial. Lancet 2005;366:1849-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hiukka A., Westerbacka J., Leinonen ES et al. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J Am Coll Cardiol 2008;52:2190-7.[Abstract/Free Full Text]
  • Goff DC Jr, Gerstein HC, Ginsberg HN et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:4i-20i.[Web of Science][Medline] [Order article via Infotrieve]
  • National Institute for Health and Clinical Excellence. Familial hypercholesterolaemia: identification and management of familial hypercholesterolaemia. NICE clinical guideline. London: NICE, 2008.
  • de Lamos JA, Blazing MA, Wiviott SD et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z Trial. JAMA 2004;292:1307-16.[Abstract/Free Full Text]
  • LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.[Abstract/Free Full Text]
  • Waters DD Safety of high-dose atorvastatin therapy. Am J Cardiol 2005;96(suppl):69F-75F.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Clinical Trial Service Unit & Epidemiological Studies Unit. SEARCH Study Results. Results from the world's largest trial of the benefits of more intensive cholesterol-lowering and of the safety of folic acid supplementation. Oxford: University of Oxford, 2008. ( www.ctsu.ox.ac.uk/search/results/search_release_091108.pdf)
  • Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statin. Lancet 2005;366:1267-78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mills EJ, Rachlis B., Wu P. et al. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol 2008;52:1769-81.[Abstract/Free Full Text]
  • Ridker PM, Danielson E., Fonseca FAH et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med 2008;359:2195-207.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 9, No. 2, 69-74 (2009)
DOI: 10.1177/1474651409103867
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Song, S. H
Right arrow Articles by Gray, T. A
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?